Lipopolysaccharide detoxification by endotoxin neutralizing protein

Area of Science:

• Biochemistry
• Immunology
• Pharmacology

Background:

• Lipopolysaccharide (LPS) is a potent endotoxin from Gram-negative bacteria, causing severe inflammatory responses and sepsis.
• Endotoxin neutralizing protein (ENP), derived from horseshoe crab amebocytes, is known to neutralize LPS.
• Effective therapeutic strategies against LPS toxicity are crucial for managing sepsis and related conditions.

Purpose of the Study:

• To evaluate the in vitro and in vivo efficacy of Endotoxin neutralizing protein (ENP) in detoxifying lipopolysaccharide (LPS).
• To assess the protective effects of ENP against lethal doses of LPS in a rat model.
• To investigate the impact of ENP on LPS-induced organ damage and survival.

Main Methods:

• In vitro detoxification of LPS by ENP was assessed using the Limulus amebocyte lysate assay.
• Rat aortic ring assays were used to evaluate the functional effects of LPS and ENP preincubation.
• Lethal doses of LPS, with or without ENP, were administered intravenously to rats to assess in vivo toxicity, survival, weight loss, and organ pathology.

Main Results:

• ENP detoxified LPS at a 1:1 weight ratio in vitro.
• Preincubation with ENP prevented LPS-induced aortic ring contraction.
• In vivo, ENP administration significantly reduced acute LPS toxicity signs, improved survival rates (100% vs. LPS/albumin group), decreased weight loss, and mitigated gross organ lesions in liver, spleen, and GALT.

Conclusions:

• Endotoxin neutralizing protein (ENP) demonstrates significant in vitro and in vivo LPS-neutralizing capabilities.
• ENP provides substantial protection against lethal endotoxemia, reducing mortality and organ damage.
• ENP represents a promising therapeutic agent for treating lipopolysaccharide toxicity and sepsis.